| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 156.37B | 71.84B | 59.16B | 51.87B | 76.86B |
| Gross Profit | 88.92B | 71.84B | 152.42B | 51.87B | 46.83B |
| EBITDA | 51.31B | 0.00 | 44.07B | 37.82B | 33.55B |
| Net Income | 40.12B | 38.23B | 32.72B | 27.33B | 24.35B |
Balance Sheet | |||||
| Total Assets | 4.49T | 4.19T | 3.87T | 3.69T | 3.64T |
| Cash, Cash Equivalents and Short-Term Investments | 810.68B | 789.29B | 418.20B | 364.93B | 389.36B |
| Total Debt | 88.60B | 78.68B | 669.39B | 630.20B | 716.53B |
| Total Liabilities | 4.13T | 3.85T | 3.55T | 3.38T | 3.34T |
| Stockholders Equity | 358.53B | 338.72B | 320.14B | 323.26B | 298.00B |
Cash Flow | |||||
| Free Cash Flow | -88.59B | -323.00M | 69.36B | 136.84B | 42.21B |
| Operating Cash Flow | -87.08B | 1.88B | 69.75B | 138.10B | 43.38B |
| Investing Cash Flow | -1.65B | -2.33B | -1.96B | -42.97B | -265.72B |
| Financing Cash Flow | -26.62B | -22.76B | 138.12B | -61.86B | 293.58B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$1.15T | 8.32 | 11.95% | 4.26% | -4.57% | 1.77% | |
71 Outperform | HK$456.53B | 10.39 | 11.77% | 5.80% | 1.90% | 12.81% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | HK$501.60B | 5.02 | 9.01% | 5.76% | -5.46% | 0.33% | |
57 Neutral | HK$206.60B | 5.64 | 6.61% | 5.53% | -8.41% | -5.52% | |
57 Neutral | HK$651.88B | 6.72 | 9.30% | 5.37% | -1.54% | -3.95% | |
52 Neutral | HK$180.84B | 5.60 | 4.68% | 9.09% | -7.28% | -5.00% |